Cardiovascular Risk Assessment For Kidney Transplantation - Utility of Computed Tomography Coronary Angiography in the Assessment of Patients Awaiting Kidney Transplantation

Launched by UNIVERSITY OF EDINBURGH · Jan 22, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how a special heart scan called computed tomography coronary angiography (CTCA) can help identify patients who are at high risk for heart problems before they receive a kidney transplant. Research has shown that even though kidney transplants can lower the risk of heart disease, many patients still face serious heart-related issues after the transplant. The goal of this study is to see if CTCA can better pinpoint which patients need extra care before undergoing a kidney transplant.

To participate in this trial, you need to be 16 years or older, have kidney failure, and be on the waitlist for a kidney transplant. You should also be able to give informed consent, meaning you understand the study and agree to participate. If you have any allergies to the contrast dye used in the CT scan or if you're being considered for certain types of combined organ transplants, you may not be eligible. If you join the study, you can expect to undergo the CTCA scan, which will help doctors assess your cardiovascular risk more accurately.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Has kidney failure and is on the waitlist for a kidney transplant
• • Age 16 years and over
• • Able to give informed consent
• Exclusion Criteria:
• • Contraindication to CT scanning, including contrast allergy
• • Patients being considered for a simultaneous kidney-pancreas, kidney-liver and/or kidney-islet transplantation
• • Inability to give informed consent